Cancer Biology & Medicine

雜志介紹

Cancer Biology & Medicine雜志介紹

《Cancer Biology & Medicine》是一本以English為主的未開放獲取國際優秀期刊，中文名稱癌癥生物學與醫學，本刊主要出版、報道醫學-MEDICINE, RESEARCH & EXPERIMENTAL領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為5.6，最新CiteScore 指數為9.8。

本刊近期中國學者發表的論文主要有：

• Circular RNAs and human glioma.

  Author: Liu J¹, Zhao K¹, Huang N¹, Zhang N¹.

• Qidong: a crucible for studies on liver cancer etiology and prevention.

  Author: Chen J^1,2, Zhu J¹, Wang G², Groopman JD³, Kensler TW^3,4.

• The PI3K/Akt/GSK-3β/ROS/eIF2B pathway promotes breast cancer growth and metastasis via suppression of NK cell cytotoxicity and tumor cell susceptibility.

  Author: Jin F¹, Wu Z¹, Hu X¹, Zhang J¹, Gao Z¹, Han X¹, Qin J¹, Li C², Wang Y^1,3.

• Estrogen and insulin synergistically promote endometrial cancer progression via crosstalk between their receptor signaling pathways.

  Author: Tian W¹, Teng F¹, Gao J¹, Gao C¹, Liu G¹, Zhang Y¹, Yu S², Zhang W³, Wang Y¹, Xue F¹.

英文介紹

Cancer Biology & Medicine雜志英文介紹

Cancer Biology & Medicine (ISSN 2095-3941) is a peer-reviewed open-access journal of Chinese Anti-cancer Association (CACA), which is the leading professional society of oncology in China. The journal quarterly provides innovative and significant information on biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China.